Genetically predicted 17β-estradiol and systemic inflammation in women: A separate-sample Mendelian randomisation analysis in the Guangzhou Biobank cohort study

J. Zhao, C. Q. Jiang, T. H. Lam, B. Liu, K. K. Cheng, S. Kavikondala, W. S. Zhang, G. M. Leung, C. M. Schooling

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Background: Many chronic diseases are characterised by low-grade systemic inflammation. Oestrogens may promote immune response consistent with sex-specific patterns of diseases. In vitro culture and animal experiments suggest oestrogens are anti-inflammatory and might thereby protect against low-grade systemic inflammation. Evidence from epidemiological studies is limited. Using a Mendelian randomisation analysis with a separate-sample instrumental variable (SSIV) estimator, we examined the association of genetically predicted 17β-estradiol with well-established systemic inflammatory markers (total white cell count, granulocyte and lymphocyte count). Methods: A genetic score predicting 17β-estradiol was developed in 237 young Chinese women (university students) from Hong Kong based on a parsimonious set of genetic polymorphisms (ESR1 (rs2175898) and CYP19A1 (rs1008805)). Multivariable linear regression was used to examine the association of genetically predicted 17β-estradiol with systemic inflammatory markers among 3096 older (50+ years) Chinese women from the Guangzhou Biobank Cohort Study. Results: Predicted 17β-estradiol was negatively associated with white blood cell count (-6.3 103/mL, 95% CI -11.4 to -1.3) and granulocyte count (-4.5 103/mL, 95% CI -8.5 to -0.4) but not lymphocyte count (-1.5 103/mL, 95% CI -3.4 to 0.4) adjusted for age only. Results were similar further adjusted for education, smoking, use of alcohol, physical activity, Body Mass Index, waist-hip ratio, age of menarche, age at menopause, use of hormonal contraceptives and hormone replacement therapy. Conclusions: Endogenous genetically predicted 17β-estradiol reduced low-grade systemic inflammatory markers (white blood cell count and granulocyte count), consistent with experimental and ecological evidence of 17β-estradiol promoting immune response. Replication in a larger sample is required.

Original languageEnglish
Pages (from-to)780-785
Number of pages6
JournalJournal of Epidemiology and Community Health
Volume68
Issue number8
DOIs
Publication statusPublished - 2014
Externally publishedYes

ASJC Scopus Subject Areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this